Vanguard Portfolio Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$50.6M Buy
612,558
+7,725
+1% +$684K ﹤0.01% 1689
2026
Q2
$58M Buy
604,833
+42,063
+7% +$4.31M ﹤0.01% 1677
2026
Q1
$61.4M Buy
+562,770
New +$53.6M ﹤0.01% 1609

Other funds holding LMAT

Vanguard Portfolio Management's LMAT Position: Q3 2026 in Review

Vanguard Portfolio Management increased its LeMaitre Vascular (LMAT) stake by 1.3% in Q3 2026, buying an estimated $684K and bringing the position to 612,558 shares worth $50.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1689.

Vanguard Portfolio Management first reported a position in LMAT in Q1 2026 and has held it in 3 quarters since. The position peaked at $61.4M in Q1 2026. 297 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

  • Vanguard Portfolio Management held 612,558 shares of LeMaitre Vascular worth $50.6M as of Q3 2026.
  • Vanguard Portfolio Management bought 7,725 LeMaitre Vascular shares in Q3 2026, an estimated $684K.
  • LeMaitre Vascular made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1689 holding.
  • Vanguard Portfolio Management first reported a position in LeMaitre Vascular in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Portfolio Management's LeMaitre Vascular position peaked at $61.4M in Q1 2026.
  • 297 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.